Absolute Bioavailability and Metabolism of Dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides (“tetraene”) after Intravenous and Oral Single Doses to Rats
Excerpt
This study assessed the absolute and relative bioavailabilities of dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides (tetraene), one of the main bioactive constituents in Echinacea, administered as pure compounds or as an Echinacea purpurea root extract preparation. Ten rats received 0.75 mg/kg dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides oral, pure and within 158.6 mg/kg Echinacea purpurea extract, or intravenous.[...]
Share and Cite
WÖLKART, K.; FRYE, R.; DERENDORF, H.; BAUER, R.; BUTTERWECK, V. Absolute Bioavailability and Metabolism of Dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides (“tetraene”) after Intravenous and Oral Single Doses to Rats. Sci. Pharm. 2009, 77, 195. https://doi.org/10.3797/scipharm.oephg.21.SL-28
WÖLKART K, FRYE R, DERENDORF H, BAUER R, BUTTERWECK V. Absolute Bioavailability and Metabolism of Dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides (“tetraene”) after Intravenous and Oral Single Doses to Rats. Scientia Pharmaceutica. 2009; 77(Short Lectures (SL)):195. https://doi.org/10.3797/scipharm.oephg.21.SL-28
Chicago/Turabian StyleWÖLKART, K., R. FRYE, H. DERENDORF, R. BAUER, and V. BUTTERWECK. 2009. "Absolute Bioavailability and Metabolism of Dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides (“tetraene”) after Intravenous and Oral Single Doses to Rats" Scientia Pharmaceutica 77, Short Lectures (SL): 195. https://doi.org/10.3797/scipharm.oephg.21.SL-28
APA StyleWÖLKART, K., FRYE, R., DERENDORF, H., BAUER, R., & BUTTERWECK, V. (2009). Absolute Bioavailability and Metabolism of Dodeca-2E,4E,8E,10E/Z-tetraenoic acid isobutylamides (“tetraene”) after Intravenous and Oral Single Doses to Rats. Scientia Pharmaceutica, 77(Short Lectures (SL)), 195. https://doi.org/10.3797/scipharm.oephg.21.SL-28